Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Other Non-Current Liabilities (2018 - 2025)

Historic Other Non-Current Liabilities for Abvc Biopharma (ABVC) over the last 8 years, with Q3 2025 value amounting to $12000.0.

  • Abvc Biopharma's Other Non-Current Liabilities fell 5327.1% to $12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $12000.0, marking a year-over-year decrease of 5327.1%. This contributed to the annual value of $21680.0 for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Abvc Biopharma's Other Non-Current Liabilities stood at $12000.0, which was down 5327.1% from $41680.0 recorded in Q2 2025.
  • In the past 5 years, Abvc Biopharma's Other Non-Current Liabilities registered a high of $41680.0 during Q2 2025, and its lowest value of $5680.0 during Q2 2023.
  • In the last 5 years, Abvc Biopharma's Other Non-Current Liabilities had a median value of $12000.0 in 2025 and averaged $15902.1.
  • Per our database at Business Quant, Abvc Biopharma's Other Non-Current Liabilities crashed by 5590.06% in 2023 and then surged by 38732.39% in 2024.
  • Over the past 5 years, Abvc Biopharma's Other Non-Current Liabilities (Quarter) stood at $10580.0 in 2021, then dropped by 24.57% to $7980.0 in 2022, then surged by 171.68% to $21680.0 in 2023, then changed by 0.0% to $21680.0 in 2024, then crashed by 44.65% to $12000.0 in 2025.
  • Its Other Non-Current Liabilities stands at $12000.0 for Q3 2025, versus $41680.0 for Q2 2025 and $21680.0 for Q1 2025.